期刊文献+

肝病患者手术及介入治疗后凝血纤溶指标监测对疗效的评估作用 被引量:2

Research on evaluating the effects of coagulation and fibrinolysis indicators on hepatopathy patients after surgery and interventional therapy
下载PDF
导出
摘要 目的探讨肝病患者手术或介入治疗后凝血及纤溶指标的变化对疗效的评估价值。方法对肝病组(100例)、肝癌组(100例)于手术或介入治疗前与后检测血浆凝血酶原时间(PT)、活化部分凝血酶原时间(APTT)、纤维蛋白原(FIB)、抗凝血酶Ⅲ(ATⅢ)活性、蛋白C(PC)活性、蛋白S(PS)活性、纤溶酶原(PLG)活性、组织型纤溶酶原活化物(t-PA)、纤溶酶原活化剂抑制物(PAI)、α2-抗纤溶酶(α2-PI)活性、纤溶酶-纤溶酶抑制物(PAP),并与正常对照组100例比较。结果与对照组比较,肝癌组介入治疗前与后PT、APTT、t-PA、PAI、PAP均明显升高(P<0.05或<0.01),FIB、ATⅢ活性、PC活性、PS活性、PLG活性、α2-PI活性均明显降低(P<0.05或<0.01);与介入治疗前比较,介入治疗后PT、APTT、t-PA降低,FIB、ATⅢ活性、PC活性、PS活性、PLG活性、α2-PI活性升高(P<0.05),而PAI-1和PAP均差异无统计学意义(P>0.05)。与对照组比较,肝病组手术治疗前与后PT、APTT、t-PA、PAP均明显升高(P<0.05或<0.01),而FIB、ATⅢ、PC活性、PS活性、PLG活性、PAI、α2-PI活性降低(P<0.01);与手术治疗前比较,肝病组手术治疗后PT、APTT、t-PA、PAP降低(P<0.05或<0.01),FIB、ATⅢ活性、PC活性、PS活性、PLG活性、PAI、α2-PI活性升高(P<0.05或<0.01)。结论肝病组和肝癌组均存在抗凝活性降低及易发纤溶。手术或介入治疗后有所改善,但未完全恢复正常。 Objective To investigate the evaluating value of curative effect about the hemostatie changes in hepatopathy patients after surgery or interventional therapy. Methods Prothrombin time (PT),activited partial thromboplastin time (AFTT),fibrinogen (Fg),antithrombin-Ⅲ activity (ATⅢ), protein C activity (PC), protein S activity (PS), plasminogen activity (PLG), tissue-type plasminogen activator (t-PA), plasminogen activator inhibitor (PAI), α2 plasmin inhibitor activity (α2-PI), plasmin-antiplasmin (PAP) level of plasma were measured among hepatopathy groups,liver cancer groups and control groups.Results Compared with control groups, PT,APTT,t-PA,PAI,PAP(P 〈0.05) level of liver cancer groups were significantly elevated at diagnosis,FIB,ATⅢ,PC,PS,PLG,α2-PI(P〈0.01) level of liver cancer groups were significantly decreased; Compared with before interventional therapy ,PT,APTT,t-PA(P〈0.01) ,level of liver cancer groups that after interventional therapy were significantly decreased,Fg,ATⅢ,PC,PS,PLG,α2-PI(P 〈0.05) elevated,PAI-1 and PAP did not display significantly difference. Compared with control groups, PT,APTT,t-PA,PAP(P〈0.05) level of hepatopathy groups were significantly elevated at diagnosis,Fg,ATⅢ,PC,PS,PLG,PAI,α2-PI(P〈0.01) decreaced ,compared with before surgery ,PT,APTT,t-PA,PAP(P〈0.05) level of hepatopathy groups that after surgery decreased,Fg,ATⅢ,PC,PS, PIG,PAI,α2-PI(P〈0.05) level elevated. Conclusion There existed decreasing of anticoagulant activity and elevating of fibrinolysis activity in both hepatopathy groups and liver cancer groups. The situation was improved after surgery and imerventional therapy,but did not recover completely.
出处 《广西医学》 CAS 2009年第3期342-344,共3页 Guangxi Medical Journal
基金 广西梧州市科学研究与技术开发计划(梧科攻200501040)
关键词 肝病 肝癌 手术 介入治疗 凝血 抗凝 纤溶指标 Hepatopathy Liver cancer Surgery Interventional therapy Blood coagulation Anticoagulant Fibrinolysis
  • 相关文献

参考文献10

二级参考文献27

  • 1黄尉国,王鸿利,张颖琪,朱立红,李耀辉,王学锋,程寅琳,邵慧珍,张鲁,葛维成.血浆D-二聚体检测及其临床应用[J].中华医学检验杂志,1995,18(2):71-74. 被引量:318
  • 2程慧敏.血浆尿激酶型血浆素原激活物作为肝细胞癌肿瘤标记物的临床探讨[J].国外医学:肿瘤学分册,1995,22:55-56.
  • 3[1]Teufelsbauer H, Proidl S, Havel M, et al. Early activation of hemostasis during cardiopulminary bypass: evidence for thrombin mediated hyperfibrinolysis. Thromb Haemost, 1992, 68(3): 250-252.
  • 4[2]Dayal S, Pati HP, Sharna MP, et al. Tissue plasminogen activator and plasminogen activator inhibitor status in Budd-Chiari syndrome.Haemostasis, 1996, 26 (5): 284-287.
  • 5[3]Huber K, Kirchheimer JC, Koringer C, et al. Hepatic synthesis and clearance of components of the fibrinolytic system in healthy volunteersand in patients with different stages of liver cirrhosis. Throm Res,1991,62: 491-500.
  • 6[6]Ben AZ, Panagou M, Patch D, et al. Hypercoagulability in patients with primary biliary cirrhosis and primary sclerosing cholangitis evaluated by thrombelastography. J Hepatol, 1997, 26(3): 554-559.
  • 7[7]Sehetz MR. Coagulation disorders in acute renal failure. Kidney Int Suppl, 1998, 66: 96-101.
  • 8[8]Okajima K. Clinical revelevance of determination of plasma AT Ⅲ and α2 antiplasmin activities in patients with DIC application of the molecularmarkers for the analysis of pathophysiology of DIC. Rinsho Byori,1994, 42 (1): 45-55.
  • 9[9]Rocha E, Paramo JA, Montes R, et al. Acute generalized, widespread bleeding. Diagnosis and management. Haematologica, 1998, 83 ( 11 ):1024-1037.
  • 10Violi F, Ferro D, Baili S, et al. Association between low-grade disseminated intravascular coagulation and endotoxemia in patients with liver cirrhosis. Gastronenterology, 1995,109:531-536.

共引文献93

同被引文献21

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部